Categories
Breaking News
Industry News
Ophthalmic Blog
Ophthalmic Research News
Write for Us
Spotlight TV
Ophthalmology Glossary
Subscribe
India Approves First 0.05% Atropine Eye Drop for Myopia Control in Children
Researchers Stimulate Retina to Reveal Never-Before-Seen Color Named “Olo”
Postoperative Pilocarpine Use After KDB Goniotomy May Reduce Long-Term Glaucoma Medication Needs
FDA Issues Complete Response Letter to Regeneron for EYLEA HD sBLA on Extended Dosing Intervals
Scientists Uncover Structural Insights into RBP3, a Key Protein in Visual Function and Retinal Health
Recommended
March 14, 2025
OBN Spotlight TV: Interview with Jeff Todd, President & CEO of Prevent Blindness
Breaking News
FDA Issues Complete Response Letter to Regeneron for EYLEA HD sBLA on Extended Dosing Intervals
Apr 22, 2025
Regeneron Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its supplemental Biologics License Application (sBLA) for EYLEA HD (aflibercept 8 mg).
BVI Medical Receives FDA 510(k) Clearance for Leos Glaucoma Surgical System
Apr 18, 2025
BVI Medical has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its innovative glaucoma surgical platform, the Laser Endoscopy Ophthalmic System (Leos).
FDA Accepts Outlook Therapeutics’ Biologics License Application for ONS-5010 in Wet AMD
Apr 10, 2025
The U.S. Food and Drug Administration (FDA) has accepted the resubmitted Biologics License Application (BLA) for ONS-5010 (bevacizumab-vikg) from Outlook Therapeutics, for the treatment of wet age-related macular degeneration (AMD).
Industry News
India Approves First 0.05% Atropine Eye Drop for Myopia Control in Children
Apr 24, 2025
Entod Pharmaceuticals has received marketing authorization from the Central Drugs Standard Control Organisation (CDSCO) for India’s first 0.05% atropine eye drop Myatroo XL.
Zhaoke Ophthalmology Enrolls First Patient in Phase 3 Trial of Cyclosporine Ophthalmic Gel for Dry Eye Disease
Apr 21, 2025
Zhaoke Ophthalmology has announced the enrollment of the first patient in its Phase 3 clinical trial evaluating Cyclosporine (CsA) Ophthalmic Gel for the treatment of moderate to severe dry eye disease (DED).
MST Forms Strategic Distribution Partnership with Mani to Expand Ophthalmic Surgical Blade Access in the U.S.
Apr 18, 2025
Microsurgical Technology (MST) has announced a strategic partnership with Japanese manufacturer Mani Inc., under which MST will serve as the exclusive distributor of Mani’s ophthalmic surgical blade portfolio in the United States.
Ophthalmic Research News
Researchers Stimulate Retina to Reveal Never-Before-Seen Color Named “Olo”
Apr 22, 2025
A multidisciplinary team has developed a novel retinal stimulation technique that enables individuals to perceive a color previously unseen by the human eye.
Postoperative Pilocarpine Use After KDB Goniotomy May Reduce Long-Term Glaucoma Medication Needs
Apr 22, 2025
Research from the University of Colorado School of Medicine suggests that using pilocarpine eye drops after Kahook Dual Blade (KDB) goniotomy surgery may improve surgical outcomes and reduce the long-term need for glaucoma medications.
Scientists Uncover Structural Insights into RBP3, a Key Protein in Visual Function and Retinal Health
Apr 21, 2025
An international team of scientists has, for the first time, mapped the three-dimensional structure of Retinol-Binding Protein 3 (RBP3).
Ophthalmic Blog
AI in Ophthalmology: Top Artificial Intelligence Tools Transforming Eye Health
Mar 07, 2025
The AI in ophthalmology sector is evolving rapidly, introducing Artificial Intelligence tools in ophthalmology that enhance diagnostic accuracy, efficiency, and accessibility.
2024 Recap: Top 8 Groundbreaking Innovations in Eye Disease Therapies and Technologies
Dec 23, 2024
The year 2024 has been a remarkable period for advancements in ophthalmology, with groundbreaking innovations reshaping the landscape of eye disease treatment and diagnosis.
2024 Recap: Top 8 FDA Approvals in Ophthalmology
Dec 16, 2024
The year 2024 has been a pivotal one for ophthalmology, with several novel FDA approvals introducing innovative treatments and technologies to the field
Ophthalmology Breaking News Subscribe
I agree to receive future communications from OBN, in accordance with the
Privacy Policy.
Categories
Breaking News
Industry News
Ophthalmic Blog
Ophthalmic Research News
Write for Us
Spotlight TV
Ophthalmology Glossary
Submit
Press Release